Sponsor hub
Georgetown University clinical trial failures
Review 42 stopped clinical trials from Georgetown University, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 6 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 27
- OTHER/UNKNOWN
- 9
- EFFICACY/FUTILITY
- 5
- SAFETY
- 1
Notable sponsors
- Georgetown University
- 42
Related phases
- Phase II
- 26
- Phase I
- 10
- Phase IV
- 3
- Unknown
- 3
Crawlable stopped-trial records
Open ExploreShowing up to 42 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Dementia With Lewy Bodies trial by Georgetown University. Stop reason: EFFICACY/FUTILITY.
Interim analysis was performed for 442 patients who completed Part I of the PROSEEK study-(CLR\_18\_06); it did not show evidence of treatment benefit in patients receiving Vodobatinib.
Phase II Peripheral Neuropathy trial by Georgetown University. Stop reason: OPERATIONAL.
Lack of accrual
Phase II DCIS trial by Georgetown University. Stop reason: OPERATIONAL.
lack of accrual
Phase II Pancreas Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
slow enrollment
Phase II Metastatic Colorectal Cancer trial by Georgetown University. Stop reason: EFFICACY/FUTILITY.
Unanticipated side effects and futility
Phase II Hepatocellular Carcinoma trial by Georgetown University. Stop reason: EFFICACY/FUTILITY.
Lack of efficacy
Phase IV Breast Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Sufficient accrual into the African American/Black patient cohort and insufficient accrual into the NHW patient cohort.
Phase II Borderline Resectable Carcinoma trial by Georgetown University. Stop reason: OPERATIONAL.
Sponsor decision and challenges in finding eligible participants
Phase II Acral Lentiginous Melanoma trial by Georgetown University. Stop reason: OPERATIONAL.
Lack of Enrollment
Phase I Solid Tumor, Adult trial by Georgetown University. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Metastatic Colorectal Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Study closed due to lack of enrollment.
Phase I Metastatic Pancreatic Cancer trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
STUDY00006987
Phase II Breast Cancer trial by Georgetown University. Stop reason: EFFICACY/FUTILITY.
Lack of efficacy
Phase II Thymoma trial by Georgetown University. Stop reason: OPERATIONAL.
Slow Accrual
Unknown Renal Transplant Recipients trial by Georgetown University. Stop reason: OPERATIONAL.
IIS - PI left the institution. Subjects just followed to study completion
Phase I Colorectal Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Low accrual--unable to meet accrual goals
Phase II Melanoma trial by Georgetown University. Stop reason: OPERATIONAL.
Recruitment difficulties.
Phase I Colorectal Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Primary investigator left the institution.
Phase II Colon Cancer trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Metastatic Pancreatic Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Issues with patient recruitment.
Unknown Esophageal Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Issues with recruitment.
Phase II Metastatic Colorectal Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Principal investigator left the institution
Phase II Breast Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Investigator left institution
Phase II Systemic Scleroderma trial by Georgetown University. Stop reason: OPERATIONAL.
Study was terminated due to inadequate enrolment
Phase I Cancer trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
Company terminated drug support
Phase I Breast Cancer trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
Decision by company to cease development of dovitinib
Phase I Chronic Lymphocytic Leukemia trial by Georgetown University. Stop reason: OPERATIONAL.
Recruitment difficulties and toxicity
Phase II Breast Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Poor accrual
Phase II Pancreatic Cancer trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
Testing of combination no longer relevant
Phase I Solid Tumors trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
Drug no longer available
Phase II Compliance trial by Georgetown University. Stop reason: OPERATIONAL.
poor recruitment
Phase II Hemophilia A trial by Georgetown University. Stop reason: OPERATIONAL.
Sponsor no longer funding study.
Phase II Chronic Pain trial by Georgetown University. Stop reason: OPERATIONAL.
poor recruitment
Phase IV Type II Diabetes trial by Georgetown University. Stop reason: OPERATIONAL.
Terminated by the sponsor due to slow enrollment
Unknown Meningitis trial by Georgetown University. Stop reason: OPERATIONAL.
Investigator left the insititution
Phase II Colon Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Poor accrual rate
Phase II Colorectal Cancer trial by Georgetown University. Stop reason: SAFETY.
Adverse Event issues.
Phase I Advanced Solid Tumors trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
Drug support withdrawn
Phase II Chronic Lymphocytic Leukemia trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
Unable to accrue patients due to change in standard CLL therapy
Phase II Pancreas Cancer trial by Georgetown University. Stop reason: EFFICACY/FUTILITY.
At interim analysis the study did not meet the response criteria to continue
Phase IV Gestational Diabetes trial by Georgetown University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Head and Neck Cancer trial by Georgetown University. Stop reason: OPERATIONAL.
Investigator decided it was not feasible to conduct this study